Xilio Therapeutics to Present at Guggenheim 6th Annual Biotechnology Conference

January 31, 2024

https://www.globenewswire.com/news-release/2024/01/31/2821540/0/en/Xilio-Therapeutics-to-Present-at-Guggenheim-6th-Annual-Biotechnology-Conference.html

WALTHAM, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., president and chief executive officer, will participate in a fireside chat at the Guggenheim 6th Annual Biotechnology Conference on Wednesday, February 7, 2024 at 12:30 pm EST.

Read more at globenewswire.com

Related news for (XLO)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.